VEGF receptor signal transduction

被引:34
作者
Li, Xiujuan [1 ]
Claesson-Welsh, Lena [1 ]
Shibuya, Masabumi [2 ]
机构
[1] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden
[2] Tokyo Med & Dent Univ, Grad Sch Med & Dent, Dept Mol Oncol, Tokyo, Japan
来源
ANGIOGENESIS: IN VITRO SYSTEMS | 2008年 / 443卷
关键词
D O I
10.1016/S0076-6879(08)02013-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Signal transduction by vascular endothelial growth factors (VEGFs) through their cognate VEGF receptor tyrosine kinases follows the consensus scheme for receptor tyrosine kinases. Thus, binding of ligand induces receptor dimerization and activation of the tyrosine kinase through transphosphorylation between receptor molecules, leading to initiation of intracellular signal transduction pathways. Certain signal transduction pathways are shared with most, if not all, receptor tyrosine kinases, whereas some may be unique (e.g., transduced only by VEGF receptors). Indications that such unique signaling pathways may be discerned only when VEGF receptors are expressed in their proper context (i.e., in endothelial cells of microcapillary origin). In this chapter, we describe a number of methods for the study of signal transduction in endothelial cells. We describe how to isolate and examine endothelial cell lines. We also describe the embryoid body model representing vasculogenesis and angiogenesis, the procedure for subcutaneous Matrigel plugs, and, finally, how to construct gene-targeted mouse models. We emphasize the need for validation of in vitro data in more complex models, where enclothelial cells reside in their proper three-dimensional context.
引用
收藏
页码:261 / 284
页数:24
相关论文
共 22 条
[1]   Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy [J].
Ferrara, N ;
Hillan, KJ ;
Novotny, W .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (02) :328-335
[2]  
FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346
[3]   ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM [J].
FONG, GH ;
ROSSANT, J ;
GERTSENSTEIN, M ;
BREITMAN, ML .
NATURE, 1995, 376 (6535) :66-70
[4]   Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice [J].
Hiratsuka, S ;
Minowa, O ;
Kuno, J ;
Noda, T ;
Shibuya, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9349-9354
[5]  
JAKOBSSON L, 2007, FASEB J 1211
[6]   Building blood vessels - stem cell models in vascular biology [J].
Jakobsson, Lars ;
Kreuger, Johan ;
Claesson-Welsh, Lena .
JOURNAL OF CELL BIOLOGY, 2007, 177 (05) :751-755
[7]   Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis [J].
Jakobsson, Lars ;
Kreuger, Johan ;
Holmborn, Katarina ;
Lundin, Lars ;
Eriksson, Inger ;
Kjellén, Lena ;
Claesson-Welsh, Lena .
DEVELOPMENTAL CELL, 2006, 10 (05) :625-634
[8]   THE PROTEINS ENCODED BY THE VPREB AND LAMBDA-5 PRE-B-CELL SPECIFIC GENES CAN ASSOCIATE WITH EACH OTHER AND WITH MU HEAVY-CHAIN [J].
KARASUYAMA, H ;
KUDO, A ;
MELCHERS, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :969-972
[9]   NEW PROCEDURE FOR DNA TRANSFECTION WITH POLYCATION AND DIMETHYLSULFOXIDE [J].
KAWAI, S ;
NISHIZAWA, M .
MOLECULAR AND CELLULAR BIOLOGY, 1984, 4 (06) :1172-1174
[10]   Early lymph vessel development from embryonic stem cells [J].
Kreuger, J ;
Nilsson, I ;
Kerjaschki, D ;
Petrova, T ;
Alitalo, K ;
Claesson-Welsh, L .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) :1073-1078